Who can get medical cannabis: the Ministry of Health has approved a list of diseases and conditions

The Ministry of Health has determined the specifics of prescribing and using medicinal cannabis. The list of diseases and conditions for which they will be prescribed was also approved. This was announced in the Ministry of Health, he reports UNN.

Details

The department stated that medicinal cannabis-based medicine will be available only with an electronic prescription from a “primary” doctor or a doctor providing specialized medical care. Data on such appointment will be entered into the electronic health care system (EHS).

In general, it refers to cases when the use of other drugs does not ensure the achievement of the expected therapeutic effect or causes side reactions that are poorly tolerated by the patient

The dosage and mode of taking the medicinal product based on cannabis will be determined by the doctor individually, taking into account the patient’s age, weight, state of health, concomitant diseases and other factors.

Rules for the transportation of medical cannabis have been approved in UkraineSeptember 3, 2024, 14:07 • 13058 views

It will be possible to prescribe medicinal cannabis if the patient has one of the following diagnoses:

Chronic or neuropathic pain (R52.2) and/or spasticity (R25.2) due to the following diseases:

• malignant neoplasms (C00 – C97);
• diabetic neuropathy (E10.4, E11.4, E12.4, E13.4, E14.4);
• multiple sclerosis (G35);
• damage to the trigeminal (G50) and facial nerve (G51);
• neuralgia due to shingles (G53.0);
• damage to nerve roots and plexuses (G54);
• compression of nerve roots and plexuses in diseases (G55);
• mononeuropathy of the upper limb (G56);
• mononeuropathy of the lower limb (G57);
• polyneuropathies and other lesions of the peripheral nervous system (G60-G64);
• cerebral palsy and other paralytic syndromes (G80 – G83);
• spinal cord injuries (S14.0, S14.1, S14.7, S24.0, S24.1, S24.7, S34.0, S34.1, S34.3, S34.7, T09.3, T91. 3);
• intracranial injuries (S06).

Nausea and vomiting (R11) due to chemotherapy (Z51.1) during treatment of neoplasms (C00–C97).

Parkinson’s disease (G20), de la Tourette’s syndrome (F95.2).

Refractory (drug-resistant) epilepsy (G40 – G41).

Diseases causing seizures in childhood: Lennox-Gastaut syndrome (G40.4), Dravet syndrome (G40.4), tuberous sclerosis (Q85.1).

Weight loss associated with anorexia (R63.0) in patients with human immunodeficiency virus disease (B20-B24).

Other diseases (A00 – T98) – only if there is an opinion of the medical and advisory commission.

Taking a cannabis-based medicinal product should be discontinued if the desired therapeutic effect is not achieved within 4-12 weeks or in the event of serious adverse reactions (including those related to mental status)

Addition

It is noted that such drugs can also be prescribed to children, but only on the condition that the ratio of cannabidiol to tetrahydrocannabinol in them is more than 20:1, and the maximum daily dose does not exceed 25 mg/kg of body weight.

The government regulated the mechanism for issuing permits for the import and export of cannabis from UkraineAugust 16, 2024, 12:53 • 24238 views

At the same time, medicines based on medical cannabis are not prescribed to pregnant and lactating women (in the case of using medicines with tetrahydrocannabinol); patients with a known or suspected personal or family history of schizophrenia or another psychotic disorder, as well as if the patient has severe personality disorders (except for depression associated with the underlying disease).

We will remind

In August of this year, the law on the legalization of medical cannabis came into force in Ukraine. It regulates the production and circulation of cannabis for the treatment of cancer and other diseases, as well as post-traumatic stress disorders.